Dana-Farber Cancer Institute Researcher Describes Advances in Breast Cancer (Endocrine therapy synergizes with SMAC mimetics to potentiate antigen presentation and tumor regression in hormone receptor-positive breast cancer)

Press/Media

PeriodJul 31 2023

Media coverage

1

Media coverage